theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Metabolic Dysfunction-Associated Liver Diseases   

Questions discussed in this category


How do you approach a patient's candidacy for simultaneous liver transplant and bariatric surgery if MASLD is the etiology of their end-stage liver disease?
1 Answer available

What is your approach on the pursuit of bariatric surgery in a patient with advanced fibrosis?
1 Answer available

If you do not have easy access to shear wave elastography (aka Fibroscan), what do you recommend for non-invasive tests to determine if a MASLD patient has clinically significant portal hypertension and risk-stratify them?
1 Answer available

How does presence of clinically significant portal hypertension change patient prognosis in MASLD?
1 Answer available

Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
1 Answer available

How do you approach an obese patient on long-term methotrexate with normal liver tests in terms of workup for underlying fatty liver?
Would you start with a baseline ultrasound and then pursue further workup such as fibroscan if fatty liver is present, or other?
1 Answer available
237042370224248237032283818122


Papers discussed in this category


International journal of molecular sciences, 2022 Mar 13
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.

Related Topics

  • Hepatology
  • Gastroenterology
  • General Hepatology
  • Primary Care
  • Endocrinology
  • Rheumatology
  • Rheumatoid Arthritis
  • Diabetes
  • Obesity Medicine
  • General Gastroenterology

Copyright © 2025 theMednet
All Rights Reserved.